UBS has recently initiated Kura Oncology Inc (KURA) stock to Buy rating, as announced on October 24, 2024, according to Finviz. Earlier, on October 14, 2024, Stifel had reduced the stock from a Buy to ...
Kura Oncology’s (NASDAQ:KURA) recently announced deal with Kirin Kyowa (OTCPK:KNBWY) for its leukemia drug ziftomenib was viewed favorably by analysts on Thursday, despite shares plunging 35% in ...
Kura Oncology (NASDAQ:KURA) stock slid 17% post-market after the company announced a collaboration deal with Japan's Kyowa Kirin (OTCPK:KNBWY) for its leukemia drug candidate ziftomenib worth up ...
Jefferies analyst Roger Song maintained a Buy rating on Kura Oncology (KURA – Research Report) today and set a price target of $28.00. The company’s shares closed last Friday at $11.04.